The publisher regrets that the following text was omitted from the original article:
*These authors have contributed equally to this work and should be considered co-first authors.
The publisher would like to apologise for any inconvenience caused.
. 2020 Aug 18;56(3):106137. doi: 10.1016/j.ijantimicag.2020.106137
Erratum to ``A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence'' [International Journal of Antimicrobial Agents 55/6 (2020) 105948]
Lisheng Wang
a,b,*, Yiru Wang
a,*, Dawei Ye
c, Qingquan Liu
a,b,⁎⁎
Lisheng Wang
aDepartment of Nephrolog, Tongji Hospital, Tongji Medical College, Huazhang University of Science and Technology, Wuhan, China
bCentre of Blood Purification, Tongji Hospital, Tongji Medical College, Huazhang University of Science and Technology, Wuhan, China
Find articles by Lisheng Wang
Yiru Wang
aDepartment of Nephrolog, Tongji Hospital, Tongji Medical College, Huazhang University of Science and Technology, Wuhan, China
Find articles by Yiru Wang
Dawei Ye
cCancer Center, Tongji Hospital, Tongji Medical College, Huazhong university of Science and Technology, Wuhan, China
Find articles by Dawei Ye
Qingquan Liu
aDepartment of Nephrolog, Tongji Hospital, Tongji Medical College, Huazhang University of Science and Technology, Wuhan, China
bCentre of Blood Purification, Tongji Hospital, Tongji Medical College, Huazhang University of Science and Technology, Wuhan, China
Find articles by Qingquan Liu
aDepartment of Nephrolog, Tongji Hospital, Tongji Medical College, Huazhang University of Science and Technology, Wuhan, China
bCentre of Blood Purification, Tongji Hospital, Tongji Medical College, Huazhang University of Science and Technology, Wuhan, China
cCancer Center, Tongji Hospital, Tongji Medical College, Huazhong university of Science and Technology, Wuhan, China
⁎⁎
Corresponding author: Qingquan Liu. qqliutj@163.com
⁎
These authors have contributed equally to this work and should be considered co-first authors.
Issue date 2020 Sep.
© 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC7434381 PMID: 32826129
This corrects the article "Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence" in volume 55 on page 105948.